@article{23e3b5f647904510b62a8a0858b35355,
title = "Letter comments on: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression",
author = "Alessandro Leonetti and Giudice, \{Giulia C.\} and Fabiana Perrone and Marcello Tiseo and Elisa Giovannetti",
note = "Funding Information: M.T. has been on advisory boards and received speakers{\textquoteright} fees for Astra-Zeneca, Pfizer, Eli-Lilly, BMS, Novartis, Roche, MSD, Boehringer Ingelheim, Otsuka, Takeda, and Pierre Fabre. M.T. has received research grants from Astra-Zeneca and Boehringer Ingelheim. A.L. received speakers{\textquoteright} fees for Astra-Zeneca. Funding Information: This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) IG2020-24444 , Cancer Center Amsterdam Foundation and Dutch Cancer Society KWF (E.G.). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = nov,
doi = "10.1016/j.ejca.2021.07.043",
language = "English",
volume = "157",
pages = "520--522",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
}
SDG 3 Good Health and Well-being